Literature DB >> 4163831

An antaminic drug, BC 105, in the prophylaxis of migraine. Pharmacological, clinical, and therapeutic experiences.

F Sicuteri, G Franchi, P L Del Bianco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163831     DOI: 10.1159/000229856

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


× No keyword cloud information.
  10 in total

Review 1.  Serotonergic agents in the management of cluster headache.

Authors:  Giorgio Lambru; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2011-04

Review 2.  Treating migraine.

Authors:  C Clough
Journal:  BMJ       Date:  1989-07-15

3.  Lack of effect of the appetite stimulant pizotifen (BC 105) on the absorption of isonicotinylhydrazine.

Authors:  E E Ohnhaus; E Nüesch
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  The central action of pizotifen.

Authors:  E Przegaliński; L Baran; W Palider; J Siwanowicz
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

5.  Comparative trial of serotonin antagonists in the management of migraine.

Authors:  J W Lance; M Anthony; B Somerville
Journal:  Br Med J       Date:  1970-05-09

6.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women.

Authors:  C M Banki
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-03-07

Review 7.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

8.  Inhibition of insulin secretion from the perfused pancreas of the rat by pizotifen.

Authors:  H G Joost
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

9.  Pizotifen increases 5-HIAA urinary excretion in male healthy volunteers.

Authors:  J L Elghozi; D Laude; P Duprat; E Mignot
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.